Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Abstract

BACKGROUND Angiotensin-converting-enzyme (ACE) inhibitors have been used for more than a decade to treat high blood pressure, despite the lack of data from randomised intervention trials to show that such treatment affects cardiovascular morbidity and mortality. The Captopril Prevention Project (CAPPP) is a randomised intervention trial to compare the… (More)

Topics

9 Figures and Tables

Cite this paper

@article{Hansson1999EffectOA, title={Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.}, author={L. Hansson and Lena Lindholm and Leo K. Niskanen and Jan Lanke and Th. Hedner and Anders Niklason and K J Luomanm{\"a}ki and Bjorn Dahl{\"o}f and Ulf H de Faire and Claes M{\"o}rlin and B. E. Karlberg and Per - Olov Wester and Johan Bj{\"o}rck}, journal={Lancet}, year={1999}, volume={353 9153}, pages={611-6} }